Market Place
Sourcing Support
Novo`s Ozempic Linked to Rare Cases of Serious Eye Disorder
09 Jun 2025 //
REUTERS
Legal battle Erupts before Novo Nordisk`s Wegovy launch
31 May 2025 //
ECONOMICTIMES
Wegovy Maker Novo Faces Fee Demand After Losing Copycat Drug Laws
29 May 2025 //
REUTERS
Zydus developing single pen for adjustable Semaglutide doses
23 May 2025 //
ECONOMICTIMES
GLP-1 diabetes drugs like Ozempic may modestly reduce cancer risks
23 May 2025 //
REUTERS
Novo Launches Access Programs As FDA Ban Hits Wegovy Copies
22 May 2025 //
PR NEWSWIRE
Time`s up For Compounders: Novo Offers One-Time Wegovy Deal
22 May 2025 //
FIERCE PHARMA
Hims & Hers Introduces 6-Month Wegovy New Customer Offer
22 May 2025 //
BUSINESSWIRE
LifeMD partners Novo Nordisk for $299 Wegovy® Bundle
22 May 2025 //
GLOBENEWSWIRE
Ascletis Starts U.S. Obesity Study with ASC47 and Semaglutide
20 May 2025 //
PR NEWSWIRE
Noom shifts to Smaller Wegovy Doses
20 May 2025 //
REUTERS
From insulin to Ozempic, history of Novo Nordisk`s CEOs
19 May 2025 //
REUTERS
Novo ousts CEO after falling behind in weight loss market
17 May 2025 //
REUTERS
Waters Corp`s India Business Boosted by Weight-Loss Drug Demand
15 May 2025 //
REUTERS
GLORY-3: Second Phase 3 Study of Mazdutide vs Semaglutide Begins
15 May 2025 //
PR NEWSWIRE
Select Trial: Wegovy® reduces cardiovascular events before weight
13 May 2025 //
PR NEWSWIRE
Zepbound outperforms Novo`s Wegovy for weight loss in trial
12 May 2025 //
REUTERS
Zepbound outperforms Wegovy in weight loss in Surmount-5 study
11 May 2025 //
PR NEWSWIRE
Novo Nordisk hopes to see US Wegovy sales recover soon
08 May 2025 //
REUTERS
Enforcement Report - Week of May 7, 2025.pdf
07 May 2025 //
FDA
Novo Nordisk: ECO 2025 - Semaglutide data reveals health benefits
06 May 2025 //
GLOBENEWSWIRE
FDA accepts Novo`s application for oral Wegovy for weight loss
03 May 2025 //
REUTERS
Novo Nordisk: CVS Caremark selects Wegovy as preferred obesity
01 May 2025 //
PR NEWSWIRE
Essence trial, Semaglutide improves MASH in adults at 72 weeks
30 Apr 2025 //
PR NEWSWIRE
Novo Nordisk to sell Wegovy via telehealth to US customers
29 Apr 2025 //
REUTERS
Novo Nordisk`s obesity drug Wegovy debuts in Thailand
29 Apr 2025 //
REUTERS
Galmed sign Term Sheet for Novel Semaglutide sublingual formulation
28 Apr 2025 //
PR NEWSWIRE
Ozempic copies restricted after US judge denies injunction
26 Apr 2025 //
REUTERS
Novo protects US patients with legal wins against compounder
25 Apr 2025 //
PR NEWSWIRE
Ozempic copies restricted after US judge denies injunction
24 Apr 2025 //
REUTERS
NABP`s Pulse Product Verification Service Adopted by 20 States
24 Apr 2025 //
PR NEWSWIRE
Novo Nordisk applies for FDA approval of semaglutide obesity pill
23 Apr 2025 //
FIERCE PHARMA
Novo Nordisk discontinues India`s top-selling insulin brand
22 Apr 2025 //
ECONOMICTIMES
PhenQ Reviews - Best OTC Alternative for Weight Loss
20 Apr 2025 //
GLOBENEWSWIRE
Lilly weight-loss pill works as well as Ozempic, shares surge
19 Apr 2025 //
REUTERS
Lilly`s oral GLP-1 delivers Ozempic like efficacy in phase 3
18 Apr 2025 //
FIERCE BIOTECH
Ozempic 6 Week Weight Loss Plan Results: Shocking Result
17 Apr 2025 //
GLOBENEWSWIRE
Novo Nordisk warns of counterfeit Ozempic® injection in US
14 Apr 2025 //
PR NEWSWIRE
Novo Nordisk warns of counterfeit Ozempic in US
14 Apr 2025 //
REUTERS
Pharma Companies Rush to Develop Weight-loss Drug Semaglutide
12 Apr 2025 //
ECONOMICTIMES
OneSource pharma gets ANVISA GMP for Bengaluru unit 2
10 Apr 2025 //
EXPRESSPHARMA
India`s anti-obesity drug market quadruples in 5 years
08 Apr 2025 //
ECONOMICTIMES
Novo Nordisk readies to bring weight-loss drug Wegovy to India
07 Apr 2025 //
ECONOMICTIMES
Novo nearly doubles earnings as Wegovy swells coffers
03 Apr 2025 //
REUTERS
Ozempic® 1 mg improves outcomes in type 2 diabetes & PAD at Meeting
29 Mar 2025 //
PR NEWSWIRE
Ozempic improves walking distance in adults with type 2 diabetes
29 Mar 2025 //
GLOBENEWSWIRE
Novo Nordisk: Rybelsus shows superior cardiovascular event reduct
29 Mar 2025 //
GLOBENEWSWIRE
CPC: Semaglutide Improves Walking Distance for PAD, Diabetes
29 Mar 2025 //
ACCESSWIRE
Novo to license obesity drug from Lexicon in up to $1 B deal
29 Mar 2025 //
FIERCE BIOTECH
Vivani Medical: Positive Preclinical Weight Loss Data for NPM-139
26 Mar 2025 //
GLOBENEWSWIRE
Novo offers cheaper Wegovy for all cash-paying patients
25 Mar 2025 //
FIERCE PHARMA
Brazil`s Hypera to launch an Ozempic generic in 2026
22 Mar 2025 //
REUTERS
Novo presents new semaglutide data at ACC 74th Scientific Sessions
17 Mar 2025 //
PR NEWSWIRE
CVS Weight Management Program Boosts Health, Cuts Costs
14 Mar 2025 //
PR NEWSWIRE
PatchMD Launches GLP-1 Support Patches For Weight Loss Patients
12 Mar 2025 //
GLOBENEWSWIRE
FDA to hold off action on weight-loss drug copies pending court ruling
11 Mar 2025 //
REUTERS
Novo trial with next-gen diabetes drug shows 15.7% weight loss
10 Mar 2025 //
REUTERS
Novo to sell Wegovy for $499 a month to cash-paying US customers
06 Mar 2025 //
PR NEWSWIRE
Novo Nordisk Launches "My Ozempic Era" Campaign For Patients
03 Mar 2025 //
PR NEWSWIRE
Lilly offers weight-loss drugs in vials at a discount
27 Feb 2025 //
PRESS RELEASE
